Biogen gets beaten up as slowing Tecfidera sales lead it to trim forecast

Eric Palmer

The speed bump that of 's hit earlier this year, its growth, has turned into a big old pothole and it has shaken investors pretty hard who have been on for the ride.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS